Telix Pharmaceuticals Limited ADR (TLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | |
| Sales | 803,794 | 516,551 | 333,892 |
| Cost of Goods | 377,356 | 180,388 | 125,012 |
| Gross Profit | 426,438 | 336,163 | 208,881 |
| Operating Expenses | 397,018 | 281,374 | 198,368 |
| Operating Income | 29,776 | 55,177 | 10,524 |
| Interest Expense | 40,868 | 24,442 | 9,150 |
| Other Income | 5,826 | 7,180 | 677 |
| Pre-tax Income | -5,266 | 37,915 | 2,051 |
| Income Tax | 1,859 | 4,230 | -1,411 |
| Net Income Continuous | -7,125 | 33,685 | 3,462 |
| Net Income | $-7,125 | $33,685 | $3,462 |
| EPS Basic Total Ops | -0.02 | 0.10 | 0.01 |
| EPS Basic Continuous Ops | -0.02 | 0.10 | 0.01 |
| EPS Diluted Total Ops | -0.02 | 0.10 | 0.01 |
| EPS Diluted Continuous Ops | -0.02 | 0.10 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.10 | 0.01 |
| EBITDA(a) | $51,185 | $60,461 | $15,004 |